» Articles » PMID: 30275445

Analysis of Chromatin Accessibility Uncovers TEAD1 As a Regulator of Migration in Human Glioblastoma

Overview
Journal Nat Commun
Specialty Biology
Date 2018 Oct 3
PMID 30275445
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The intrinsic drivers of migration in glioblastoma (GBM) are poorly understood. To better capture the native molecular imprint of GBM and its developmental context, here we isolate human stem cell populations from GBM (GSC) and germinal matrix tissues and map their chromatin accessibility via ATAC-seq. We uncover two distinct regulatory GSC signatures, a developmentally shared/proliferative and a tumor-specific/migratory one in which TEAD1/4 motifs are uniquely overrepresented. Using ChIP-PCR, we validate TEAD1 trans occupancy at accessibility sites within AQP4, EGFR, and CDH4. To further characterize TEAD's functional role in GBM, we knockout TEAD1 or TEAD4 in patient-derived GBM lines using CRISPR-Cas9. TEAD1 ablation robustly diminishes migration, both in vitro and in vivo, and alters migratory and EMT transcriptome signatures with consistent downregulation of its target AQP4. TEAD1 overexpression restores AQP4 expression, and both TEAD1 and AQP4 overexpression rescue migratory deficits in TEAD1-knockout cells, implicating a direct regulatory role for TEAD1-AQP4 in GBM migration.

Citing Articles

AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer.

Zheng G, Yan Z, Zou J, Zou X, Chai K, Zhang G Front Oncol. 2025; 15:1520808.

PMID: 39963114 PMC: 11830605. DOI: 10.3389/fonc.2025.1520808.


Dietary Palmitic Acid Drives a Palmitoyltransferase ZDHHC15-YAP Feedback Loop Promoting Tumor Metastasis.

Wang J, Shen D, Jiang J, Hu L, Fang K, Xie C Adv Sci (Weinh). 2024; 12(6):e2409883.

PMID: 39686664 PMC: 11809420. DOI: 10.1002/advs.202409883.


Cell and gene therapy in neuro-oncology.

Varela M, Comba A, Faisal S, Argento A, Pena Aguelo J, Candolfi M Handb Clin Neurol. 2024; 205:297-315.

PMID: 39341660 PMC: 11441620. DOI: 10.1016/B978-0-323-90120-8.00009-5.


Deciphering the role of transcription factors in glioblastoma cancer stem cells.

Li K, Li H, He A, Zhang G, Jin Y, Cai J Acta Biochim Biophys Sin (Shanghai). 2024; 56(9):1245-1255.

PMID: 38716541 PMC: 11543521. DOI: 10.3724/abbs.2024061.


Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma.

Licon-Munoz Y, Avalos V, Subramanian S, Granger B, Martinez F, Varela S bioRxiv. 2024; .

PMID: 38712234 PMC: 11071523. DOI: 10.1101/2024.04.24.590852.


References
1.
Hoelzinger D, Mariani L, Weis J, Woyke T, Berens T, McDonough W . Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia. 2005; 7(1):7-16. PMC: 1490313. DOI: 10.1593/neo.04535. View

2.
Caren H, Stricker S, Bulstrode H, Gagrica S, Johnstone E, Bartlett T . Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest. Stem Cell Reports. 2015; 5(5):829-842. PMC: 4649264. DOI: 10.1016/j.stemcr.2015.09.014. View

3.
Reddy B, Irvine K . Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev Cell. 2013; 24(5):459-71. PMC: 3624988. DOI: 10.1016/j.devcel.2013.01.020. View

4.
Selagea L, Mishra A, Anand M, Ross J, Tucker-Burden C, Kong J . EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform. FASEB J. 2016; 30(12):4098-4108. PMC: 5102110. DOI: 10.1096/fj.201600550R. View

5.
Fan S, Zhao C, Zhang L, Dai S, Ren J, Zhang X . Knockdown of PFTK1 Inhibits the Migration of Glioma Cells. J Mol Neurosci. 2015; 57(2):257-64. DOI: 10.1007/s12031-015-0600-z. View